Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inhibitors”

3,705 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,705 results

Testing effectiveness (Phase 2)Study completedNCT05086627
What this trial is testing

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital 118
Not applicableStudy completedNCT07531173
What this trial is testing

Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events

Who this might be right for
Chronic Kidney Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 8,688
Large-scale testing (Phase 3)WithdrawnNCT06585969
What this trial is testing

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerER-positive Breast CancerLuminal B+2 more
Danish Breast Cancer Cooperative Group
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Post-approval studies (Phase 4)Looking for participantsNCT06952608
What this trial is testing

Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors

Who this might be right for
Intraoperative HypotensionCiprofolRenin-angiotensin System Inhibitors
Second Affiliated Hospital, School of Medicine, Zhejiang University 140
Post-approval studies (Phase 4)Study completedNCT00688480
What this trial is testing

Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?

Who this might be right for
Kidney DiseaseLeft Ventricular Hypertrophy
A. D. Struthers 67
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Not applicableStudy completedNCT06007274
What this trial is testing

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Biomarkers
Institut Mutualiste Montsouris 300
Not applicableUnknownNCT05640024
What this trial is testing

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

Who this might be right for
Ovarian Cancer
Yonsei University 54
Not applicableStudy completedNCT06370247
What this trial is testing

First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy

Who this might be right for
SGLT2 Inhibitors, First Time UseType2 DiabetesFasting in Ramadan
Sohag University 60
Not applicableStudy completedNCT01579955
What this trial is testing

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 321
Post-approval studies (Phase 4)Study completedNCT01535235
What this trial is testing

ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study

Who this might be right for
HIV
University of California, San Francisco 31
Not applicableLooking for participantsNCT07041320
What this trial is testing

Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)Elderly (People Aged 65 or More)
Anhui Chest Hospital 40
Not applicableEnded earlyNCT02455024
What this trial is testing

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®

Who this might be right for
Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
Ariad Pharmaceuticals 3
Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Not applicableStudy completedNCT03575260
What this trial is testing

500mg Fulvestrant Versus Exemestane in MBC

Who this might be right for
Breast Cancer
Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT01619150
What this trial is testing

A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain

Who this might be right for
Osteoarthritis
C4Pain 39
Post-approval studies (Phase 4)WithdrawnNCT02768220
What this trial is testing

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

Who this might be right for
SGLT-2 InhibitorsAdvanced Glycation End ProductsDiabetes
Northwell Health
Testing effectiveness (Phase 2)Study completedNCT02294682
What this trial is testing

A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae

Who this might be right for
Gonorrhea
GlaxoSmithKline 106
Load More Results